Medication info
Famotidine Tablet (Famotidine)

Famotidine Tablet (Famotidine)

Prescription medicationTabletOral
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Wonkwang Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 202001943 · Approved 2020.03.19 · Insurance code 662601040

Summary

Main use
Gastric acid disorders (ulcers, reflux esophagitis, etc.), upper gastrointestinal bleeding, improvement of gastritis lesions
Who takes it
Adults
Adult dose
1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, and Zollinger-Ellison syndrome: Adults should take famotidine 20mg orally twice daily (after breakfast and dinner, or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection; switch to oral administration once oral intake is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults should take famotidine 10mg orally twice daily (after breakfast and dinner, or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose appropriately according to age and symptoms.

Ingredients

Manufacturer
Wonkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Gastric acid disorders (ulcers, reflux esophagitis, etc.), upper gastrointestinal bleeding, improvement of gastritis lesions

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosion
  • bleeding
  • erythema
View approved original text

This medication is used for the treatment of gastric and duodenal ulcers, anastomotic ulcers, and upper gastrointestinal bleeding types of peptic ulcers. It is also effective for conditions associated with mucosal bleeding, such as acute stress ulcers and hemorrhagic gastritis. It helps to improve gastroesophageal reflux disease and Zollinger-Ellison syndrome, as well as gastric mucosal lesions, erosion, bleeding, erythema, and edema. It is used in the treatment of acute exacerbations of acute and chronic gastritis to protect the gastric mucosa and relieve symptoms. This medication is utilized to improve various symptoms of gastrointestinal diseases, aiding patients' digestive health.

How to take

Adult dose

1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, and Zollinger-Ellison syndrome: Adults should take famotidine 20mg orally twice daily (after breakfast and dinner, or at bedtime), or 40mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection; switch to oral administration once oral intake is possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, swelling) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults should take famotidine 10mg orally twice daily (after breakfast and dinner, or at bedtime), or 20mg orally once daily (at bedtime). Adjust the dose appropriately according to age and symptoms.

Precautions

This medication should not be used by patients who have previously shown allergic reactions to its ingredients or other H2 receptor antagonists. Additionally, this medication contains lactose; hence, it should not be administered to patients with genetic issues such as lactose intolerance, lactose deficiency, or glucose-galactose malabsorption. Patients with hypersensitivity, reduced kidney function, heart diseases, liver dysfunction, and elderly patients should use this medication with caution. In particular, patients with reduced kidney function may have increased serum concentration of the drug; therefore, dosage should be reduced or dosing intervals extended. During treatment with this medication, serious allergic reactions, blood disorders, severe skin and mucosal diseases, liver dysfunction, muscle damage, cardiac arrhythmias, consciousness disorders, nephritis, and pneumonia may occur, so careful monitoring is necessary. If any of these symptoms appear, the medication should be immediately discontinued, and appropriate treatment sought. Common side effects may include rash, urticaria, changes in blood cell counts, gastrointestinal symptoms, blood pressure changes, respiratory issues, liver function abnormalities, neuropsychiatric symptoms, endocrine disturbances, and arthralgia; if such symptoms occur, the medication should be discontinued. During treatment, the patient's condition should be closely monitored, and the medication should be used at the minimum effective dose, with a switch to other therapies recommended if ineffectiveness is noted. This medication dissolves in the mouth but is not absorbed through the oral mucosa, so it should be swallowed with saliva or water. Also, patients undergoing hemodialysis should be cautious if taking this medication with phosphate binders, as it may reduce the effectiveness of calcium carbonate. This medication may interact with certain antifungal agents or some anticancer drugs, reducing its efficacy; therefore, consultation with a doctor or pharmacist is advised when taken with other medications. Elderly patients may have reduced kidney function, resulting in increased serum drug concentration, so caution is necessary with a dosage reduction or extended dosing intervals. Pregnant women should only use this medication when the benefits outweigh the risks, as its safety has not been adequately established, and it is recommended that breastfeeding women discontinue breastfeeding as this medication may pass into breast milk. For pediatrics, caution is needed as the safety of this medication has not been established.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • systemic rash
  • angioedema
  • facial edema
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 89 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • general malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • mucous membrane syndrome
  • Riel syndrome
  • toxic epidermal necrolysis
  • liver dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • serum muscle enzyme elevation
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • seizures
  • tonic-clonic seizures
  • rigid seizures
  • clonic seizures
  • interstitial nephritis
  • acute renal failure
  • rash
  • skin eruption
  • abnormal blood test
  • interstitial pneumonia
  • high fever
  • cough
  • dyspnea
  • abnormal chest X-ray
  • under-contraction
  • rash
  • skin eruption
  • urticaria
  • erythema
  • facial edema
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • loose stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated ALP
  • elevated total bilirubin
  • elevated LDH
  • hepatitis
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • sensory disturbances
  • heaviness in the head
  • reversible confusional state
  • depression
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and it’s best to keep it at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.